Exercise Training for Heart Disease
(EXCEED2 Trial)
Recruiting in Palo Alto (17 mi)
Overseen ByJennifer Reed, PhD
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Ottawa Heart Institute Research Corporation
No Placebo Group
Approved in 1 jurisdiction
Trial Summary
What is the purpose of this trial?This study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity continuous training (MICT). After randomization, patients will exercise twice a week, for 12 weeks. The sessions will be conducted virtually. Patients will undergo a maximal exercise test, cardiometabolic indicators (height (cm), body mass (kg), body composition (%), waist circumference (cm) and, resting blood pressure) and complete questionnaires about quality of life, mental health, self-determined motivation, self-efficacy and enjoyment.
Eligibility Criteria
This trial is for women with coronary heart disease (CHD) who are interested in participating in a virtual exercise program. The study requires participants to train twice a week for 12 weeks, but specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
I can read and understand English or French.
I am a woman who had a heart procedure or event at least 4 weeks ago.
Patient is able to perform a symptom limited CPET
Exclusion Criteria
Patient currently participating in routine exercise training (>2x/week)
I have severe heart or lung conditions.
I am not willing to be assigned randomly to high-intensity or moderate-intensity exercise.
+3 more
Participant Groups
The study is testing the effectiveness of two different virtual exercise programs: high-intensity interval training (HIIT) and moderate-to-vigorous intensity continuous training (MICT). Women will be randomly assigned to one of these programs to see which is better at improving exercise capacity and heart health.
2Treatment groups
Experimental Treatment
Group I: standard care + moderate-intensity continuous exercise trainingExperimental Treatment1 Intervention
2 days/week Warm-up: 60-70% peak HR - 10min Training: 70-85% peak HR - 35min Cool-down: 60-70% peak HR - 15min
Group II: standard care + high-intensity interval trainingExperimental Treatment1 Intervention
2 days/week Warm-up: 60-70% peak HR - 10min Training: 85-95% peak HR - 25 minutes (4x4-minutes of high-intensity intervals interspersed with 3 minutes of low-intensity intervals) Cool-down: 60-70% peak HR - 10min
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Ottawa Heart InstituteOttawa, Canada
Loading ...
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research CorporationLead Sponsor